Teachers Retirement System Of The State Of Kentucky Iovance Biotherapeutics, Inc. Transaction History

Teachers Retirement System Of The State Of Kentucky

$11.5 Billion
Q3 2024

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 22, 2022	SELL	$9.53 - $13.11 $1.77 Million - $2.43 Million	-185,549 Reduced 68.42%	85,655 $821,000
Q1 2022 Jun 07, 2022	BUY	$12.38 - $19.1 $684,254 - $1.06 Million	55,271 Added 25.6%	271,204 $4.52 Million
Q4 2021 Feb 08, 2022	BUY	$16.55 - $27.63 $385,681 - $643,889	23,304 Added 12.1%	215,933 $4.12 Million
Q3 2021 Nov 10, 2021	BUY	$20.35 - $26.63 $880,198 - $1.15 Million	43,253 Added 28.96%	192,629 $4.75 Million
Q2 2021 Jul 28, 2021	BUY	$16.33 - $33.07 $90,043 - $182,347	5,514 Added 3.83%	149,376 $3.89 Million
Q1 2021 May 19, 2021	BUY	$28.67 - $52.59 $1.29 Million - $2.37 Million	45,115 Added 45.69%	143,862 $4.56 Million
Q4 2020 Mar 08, 2021	BUY	$28.04 - $50.26 $2.77 Million - $4.96 Million	98,747 New	98,747 $4.58 Million
Q3 2020 Dec 02, 2020	SELL	$27.75 - $36.3 $439,143 - $574,447	-15,825 Closed	0 $0
Q2 2020 Sep 04, 2020	SELL	$27.21 - $41.0 $399,415 - $601,839	-14,679 Reduced 48.12%	15,825 $434,000
Q1 2020 Jul 16, 2020	SELL	$19.54 - $38.85 $287,413 - $571,444	-14,709 Reduced 32.53%	30,504 $913,000
Q4 2019 Feb 13, 2020	BUY	$17.95 - $29.41 $530,817 - $869,712	29,572 Added 189.07%	45,213 $1.25 Million
Q3 2019 Nov 07, 2019	BUY	$17.99 - $26.0 $162,647 - $235,066	9,041 Added 136.98%	15,641 $285,000
Q2 2019 Oct 03, 2019	BUY	$9.78 - $24.52 $64,547 - $161,832	6,600 New	6,600 $162,000

Others Institutions Holding IOVA

# of Institutions

320

Shares Held

239M

Call Options Held

3.77M

Put Options Held

1.7M

View Full List

About IOVANCE BIOTHERAPEUTICS, INC.

Ticker IOVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 157,800,992
Market Cap $977M
Description
Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...

More about IOVA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Teachers Retirement System Of The State Of Kentucky, based on Form 13F filings with the SEC.

News

Stay updated on Teachers Retirement System Of The State Of Kentucky with notifications on news.

Account